Latest Insights: 2023 Healthcare, Technology and Consumer Trends
By Laureen DeBuono
FLG Partners’ C-suite consulting and advisory practice supports a diverse continuum of industry sectors, from healthcare and life sciences to technology (SaaS and software to med tech and hardware) and consumer, from e-commerce to CPG. Our partners regularly attend many industry conferences and networking opportunities to stay abreast of the…Read More
Read MoreFundraising Choices in Life Sciences: What, When & Why?
By Linda Rubinstein
This article is the second in a two-part series about fundraising strategies for life science companies. In our last article, A Menu of Financing Alternatives for Life Science Companies, we looked at the continuum of choices available to life science companies who are actively engaged in fundraising to power up…Read More
Read MoreA Menu of Financing Alternatives for Life Science Companies
By Linda Rubinstein
This article is the first in a two-part series about fundraising strategies for life science companies. A Menu of Financing Alternatives for Life Science Companies Fundraising Choices in Life Sciences: What, When & Why? Life science companies, from emerging to evolved, therapeutics to diagnostics, solo or partnered, are constantly fundraising….Read More
Read MoreLife Sciences Companies: Sell Now or Sell Later?
By Mark Murray
Life sciences companies in their early stages are in constant need of capital to continue along their path to meeting clinical milestones. Most are pre-revenue and focused on successful completion of Phase I and II clinical trials. And with strong clinical data, these investment prospects are attractive to sources of…Read More
Read More